Last reviewed · How we verify
anti-EX02 CAR T cells
At a glance
| Generic name | anti-EX02 CAR T cells |
|---|---|
| Sponsor | Zhang Xiaofeng,MD |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- anti-EX02 CAR T cells CI brief — competitive landscape report
- anti-EX02 CAR T cells updates RSS · CI watch RSS
- Zhang Xiaofeng,MD portfolio CI